IOMED in the United Kingdom

New IOMED is operative in the UK

Brexit and clinical research

The United Kingdom departed from the European Union on January 1, 2021. Therefore, the UK government has issued the following documents:

Registration of clinical trials for investigational medical products and publication of summary results from 1 January 2021 (1 September 2020)


Guidance on substantial amendments to a clinical trial from 1 January 2021 (1 September 2020)


These guidance documents set out all details in relation to clinical trials in UK, as from January 1st, 2021.

Brexit and data flow

Independently of the country in which IOMED works:

It processes data for anonymization in the site's server.

It does not store any data that has been through our anonymization process outside of the site.

It performs a double anonymization technique, before any other data processing task is performed.

In addition to this, IOMED is compliant with all current EU and UK data security regulations. All of this allows IOMED to have partner hospitals both in the EU and the UK.

In December 2020, the UK and the EU reached a trade and cooperation agreement, which, among other topics, sets the framework to regulate the data exchange between both parties. In this context, as of January 2021, the UK and the EU are in the processof negotiating an Adequacy Decision to address the issue of sharing personal data. This agreement will allow the free flow of ddata to continue as it has until Brexit, and in the same way as it does with countries such as Israel, New Zealand and Japan. IOMED will continue to monitor and update its processes as more information becomes available.